Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2003
05/15/2003US20030091562 Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
05/15/2003US20030091561 Anticancer agents
05/15/2003US20030091548 Gene therapy for the prevention of autoimmune disease
05/15/2003US20030091547 Antiischemic agents; administering endothelial cells, bone marrow culture
05/15/2003US20030091545 Insoluble collagen matrix containing cells, microspheresc and promoters
05/15/2003US20030091543 Therapeutic cell preparation grafts and methods of use thereof
05/15/2003US20030091542 Tissue engineering; wound healing agents; culture product
05/15/2003US20030091541 Method of inducing immunotolerance in an organ transplantation recipient
05/15/2003US20030091538 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
05/15/2003US20030091535 Mutant virus with defective genome; genetic engineering
05/15/2003US20030090959 Apparatus and method for mixing specimens in vials
05/15/2003US20030089731 Article dispensing apparatus and method
05/15/2003US20030088963 Container uncapping mechanism and method
05/15/2003CA2467853A1 Antibody stimulating il-1ra production
05/15/2003CA2466880A1 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
05/15/2003CA2466391A1 Polyamide modulators of cox2 transcription
05/15/2003CA2466342A1 Characterization and isolation of subsets of human embryonic stem cells (hes) and cells associated or derived therefrom
05/15/2003CA2466203A1 Cross-species somatic cell nuclear transfer using rabbit oocyte
05/15/2003CA2466198A1 Somatic cell derived embryonic stem cells and their differentiated progenies
05/15/2003CA2466138A1 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
05/15/2003CA2466128A1 Antibodies to cd40
05/15/2003CA2466088A1 Method for selecting genetically transformed cells
05/15/2003CA2465951A1 Transcription factor stress-related polypeptides and methods of use in plants
05/15/2003CA2465950A1 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
05/15/2003CA2465921A1 Novel compositions and methods for cancer
05/15/2003CA2465908A1 Adipose tissue-derived stromal cells for the repair of corneal and intra-orbital defects and uses thereof
05/15/2003CA2465476A1 Methods and compositions for correction of cardiac conduction disturbances
05/15/2003CA2465239A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003CA2464765A1 Type 2 cytokine receptor and nucleic acids encoding same
05/15/2003CA2464007A1 Methods for treating ocular neovascular diseases
05/15/2003CA2462653A1 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
05/15/2003CA2462462A1 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
05/14/2003EP1310571A2 A Method of detecting and/or identifying adeno-associated virus (AVV) sequences and isolating novel sequences identified thereby
05/14/2003EP1310558A2 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
05/14/2003EP1310552A2 Posh nucleic acids, polypeptides and related methods
05/14/2003EP1310260A1 Mixed chimerism and tolerance
05/14/2003EP1310166A1 Transgenic non-human mammal and method of constructing the same, animal disease model and method of clarifying gene function
05/14/2003EP1309869A1 Designing and screening random libraries of compounds
05/14/2003EP1309726A2 Rna sequence-specific mediators of rna interference
05/14/2003EP1309722A1 Use of microbial dna sequences for the identification of human diseases
05/14/2003EP1309709A2 Methods for the replacement, translocation and stacking of dna in eukaryotic genomes
05/14/2003EP1309707A1 Assays for alternative lengthening of telomeres
05/14/2003EP1309706A2 Modulation of stem cell differentiation
05/14/2003EP1309705A2 Multivalent target binding protein
05/14/2003EP1309704A2 Regulation of human membrane-type serine protease
05/14/2003EP1309703A2 Kallikrein gene
05/14/2003EP1309700A2 Human phosphodiesterases
05/14/2003EP1309699A2 Elongase genes and uses thereof
05/14/2003EP1309698A2 A cytochrome p450 enzyme associated with the synthesis of delta-12 -epoxy groups in fatty acids of plants
05/14/2003EP1309697A2 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme
05/14/2003EP1309695A2 Polyketides and their synthesis
05/14/2003EP1309693A2 Anti-dual integrin antibodies, compositions, methods and uses
05/14/2003EP1309692A2 Anti-il-12 antibodies, compositions, methods and uses
05/14/2003EP1309691A2 Anti-tnf antibodies, compositions, methods and uses
05/14/2003EP1309690A2 Mfq-111, a novel human gtpase like protein
05/14/2003EP1309687A2 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof
05/14/2003EP1309685A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
05/14/2003EP1309684A2 Polynucleotides and polypeptides encoded thereby
05/14/2003EP1309682A2 Tetraspan protein and uses thereof
05/14/2003EP1309679A2 Human genes and gene expression products
05/14/2003EP1309678A2 Use of a transgene encoding a vertebrate phytase to increase capacity to utilize phytic acid in livestock feed
05/14/2003EP1309673A2 Pancreatic progenitor cells
05/14/2003EP1309672A1 Method of producing infectious reovirus
05/14/2003EP1309626A2 Cng2b: a putative human cyclic nucleotide-gated ion channel
05/14/2003EP1309625A2 Therapeutic compounds for ovarian cancer
05/14/2003EP1309622A2 Lat peptides and their use in assays for identifying immunosuppressants
05/14/2003EP1309620A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
05/14/2003EP1309606A1 T1r taste receptors and genes encoding same
05/14/2003EP1309603A1 Nucleic acids comprising regions of the rat peg-3 promoter and uses thereof
05/14/2003EP1309361A1 Scaffolds for tissue engineered hair
05/14/2003EP1309342A2 Production of chimeric human papillomavirus
05/14/2003EP1309341A2 Prevention and treatment of alzheimer's disease
05/14/2003EP1309340A1 High mannose proteins and methods of making high mannose proteins
05/14/2003EP1267940B1 Compounds for targeting
05/14/2003EP1179046A4 Lineage-restricted precursor cells isolated from mouse neural tube and mouse embryonic stem cells
05/14/2003EP1162875B1 Plants transformed with thioredoxin
05/14/2003EP1036161A4 Chondrocyte-like cells useful for tissue engineering and methods
05/14/2003EP1036095A4 Oxygen-transporting albumin-based blood replacement composition and blood volume expander
05/14/2003EP0814838B1 Antigen presenting system and activation of t-cells
05/14/2003EP0804072B1 Method of cultivating macrophages
05/14/2003EP0800575B1 Method for gene transfer into cells activated out of a quiescent state
05/14/2003EP0666929B1 Method of inhibiting replication of hyperproliferative cells
05/14/2003EP0640141B1 Nucleic acid fragments and methods for increasing the lysine and threonine content of the seeds of plants
05/14/2003EP0594669B1 Growth factor-responsive neural progenitor cells which can be proliferated in vitro.
05/14/2003CN1418253A Proteins producing altered immunogenic response and methods of making and using the same
05/14/2003CN1418250A Signal sequence trapping
05/14/2003CN1418248A Altered strain of modified vaccinia virus ankara (MVA)
05/14/2003CN1418225A Monoclonal antibodies to the human ldl receptor, their production and use
05/14/2003CN1418224A TCF responsive element
05/14/2003CN1418115A Coating that promotes endothelial Cell adherence
05/14/2003CN1417334A Recombinant gene of soluble part in tumor necrosis factor acceptor and its fusion gene and product
05/14/2003CN1417332A Recombinant gene of soluble part in cytolytic T cell relative antigen 4 and its fusion gene and product
05/14/2003CN1416909A Preparation method of artificial endometrium
05/14/2003CN1108374C Magnetosensitive microcarrier for culturing animal cells and its preparing process
05/14/2003CN1108373C Isolated biolgical synthesis of elliptone
05/13/2003US6563024 Process for transformation of mature trees of Eucalyptus plants
05/13/2003US6563021 Production of cotton fiber with improved fiber characteristics
05/13/2003US6563019 Genetically engineering disease and stress resistant plants; obtain cells, incubate with vector contain iron binding protein, transform cells, recover transformed cells, express vector, monitor and evaluate cell activity
05/13/2003US6563018 Comprising sequence for GAL4 transcription activator and promoter sequence, wherein expression regulatory sequences are integrated in the P-element sequence in such manner that their downstreams are in opposite directions
05/13/2003US6563016 Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses
1 ... 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 ... 1827